Literature DB >> 2680389

Interaction of anticancer drugs with hepatic monooxygenase enzymes.

G A Le Blanc1, D J Waxman.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2680389     DOI: 10.3109/03602538909103550

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  8 in total

Review 1.  Cytochromes P450 and drug resistance.

Authors:  J Doehmer; A R Goeptar; N P Vermeulen
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

2.  A mutation in exon 7 of the human cytochrome P-4501A1 gene as marker for sensitivity to anti-cancer drugs?

Authors:  W H Peters; H M Roelofs
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.

Authors:  G I Murray; V E Taylor; J A McKay; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

4.  The lithocholic acid 6 beta-hydroxylase cytochrome P-450, CYP 3A10, is an active catalyst of steroid-hormone 6 beta-hydroxylation.

Authors:  T K Chang; J Teixeira; G Gil; D J Waxman
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

5.  In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate.

Authors:  M A Kamal; F H Nasim; A A al-Jafari
Journal:  Mol Cell Biochem       Date:  1996-06-07       Impact factor: 3.396

6.  Xenobiotic metabolising enzyme expression in colonic neoplasia.

Authors:  J A McKay; G I Murray; R J Weaver; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

7.  Cytochrome P450 expression in oesophageal cancer.

Authors:  G I Murray; D Shaw; R J Weaver; J A McKay; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

8.  Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer.

Authors:  M C McFadyen; M E Cruickshank; I D Miller; H L McLeod; W T Melvin; N E Haites; D Parkin; G I Murray
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.